(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -15.82%781.81M | 9.89%1.83B | 8.82%928.7M | 17.59%1.67B | 17.02%853.45M | 13.60%1.42B | 11.96%729.32M | -14.49%1.25B | -14.79%651.41M | 8.71%1.46B |
Operating income | -15.82%781.81M | 9.89%1.83B | 8.82%928.7M | 17.59%1.67B | 17.02%853.45M | 13.60%1.42B | 11.96%729.32M | -14.49%1.25B | -14.79%651.41M | 8.71%1.46B |
Cost of sales | 8.13%-580.95M | -9.13%-1.26B | -2.94%-632.37M | -5.78%-1.16B | -19.05%-614.32M | -2.74%-1.09B | -8.46%-516.01M | 1.56%-1.06B | 14.32%-475.78M | -1.05%-1.08B |
Operating expenses | 8.13%-580.95M | -9.13%-1.26B | -2.94%-632.37M | -5.78%-1.16B | -19.05%-614.32M | -2.74%-1.09B | -8.46%-516.01M | 1.56%-1.06B | 14.32%-475.78M | -1.05%-1.08B |
Gross profit | -32.22%200.85M | 11.62%567.57M | 23.92%296.33M | 57.60%508.49M | 12.10%239.13M | 77.09%322.65M | 21.45%213.31M | -51.61%182.2M | -16.02%175.63M | 38.96%376.52M |
Selling expenses | -20.76%-40.48M | -67.08%-69.11M | -21.40%-33.52M | 29.92%-41.36M | 10.56%-27.61M | 53.55%-59.02M | 16.35%-30.87M | -40.00%-127.08M | 23.74%-36.9M | -8.88%-90.77M |
Administrative expenses | -0.71%-154.02M | -5.97%-311.19M | -5.06%-152.94M | 1.74%-293.67M | 10.19%-145.57M | 5.63%-298.86M | -8.30%-162.09M | 0.87%-316.68M | -0.96%-149.66M | 9.05%-319.45M |
Research and development expenses | 19.00%-22.29M | -40.18%-53.61M | -36.70%-27.52M | -33.89%-38.24M | -218.71%-20.13M | 24.67%-28.56M | 68.25%-6.32M | 0.75%-37.92M | -18.80%-19.9M | ---38.21M |
Impairment and provision | ---- | 99.60%-427K | ---- | -1,305.64%-107.1M | ---- | 98.35%-7.62M | ---- | ---460.49M | ---377.34M | ---- |
-Impairment of intangible assets | ---- | ---- | ---- | ---101.14M | ---- | ---- | ---- | ---- | ---- | ---- |
-Impairment of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | 85.98%-11.96M | ---- | ---85.27M | ---- | ---- |
-Goodwill impairment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---385.77M | ---377.34M | ---- |
-Other impairment is provision | ---- | 92.83%-427K | ---- | -237.28%-5.95M | ---- | -58.91%4.34M | ---- | --10.56M | ---- | ---- |
Operating interest expense | ---- | ---- | ---- | ---- | 7.68%-7.08M | ---- | 13.42%-7.67M | ---- | -314.17%-8.86M | ---- |
Special items of operating profit | 186.73%33.27M | -215.30%-24.92M | -380.81%-38.36M | -66.92%21.61M | -33.24%13.66M | 328.23%65.32M | 85.14%20.46M | -176.10%-28.62M | -70.36%11.05M | -26.77%37.61M |
Operating profit | -60.60%17.33M | 117.83%108.33M | -16.06%43.99M | 915.26%49.73M | 95.31%52.4M | 99.23%-6.1M | 106.61%26.83M | -2,199.49%-788.59M | -1,412.67%-405.97M | 73.85%-34.29M |
Financing cost | 0.94%-6.56M | 3.99%-13.51M | ---6.62M | 3.32%-14.08M | ---- | 22.35%-14.56M | ---- | -72.82%-18.75M | ---- | ---10.85M |
Share of profits of associates | 8.97%-2.2M | 50.99%-4.11M | -36.07%-2.42M | -103.15%-8.39M | 26.72%-1.78M | -246.77%-4.13M | -232.19%-2.43M | -263.11%-1.19M | -215.32%-730K | -169.64%-328K |
Share of profit from joint venture company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -1,204.35%-38.36M |
Earning before tax | -75.48%8.57M | 232.67%90.7M | -30.97%34.95M | 209.98%27.27M | 107.44%50.63M | 96.93%-24.79M | 106.00%24.41M | -864.45%-808.53M | -1,432.47%-406.7M | 47.28%-83.83M |
Tax | -103.32%-1.51M | 203.42%71.51M | 489.45%45.54M | 175.58%23.57M | 191.07%7.73M | -160.21%-31.18M | -75.53%2.65M | 73.70%51.79M | 47.10%10.85M | -6.51%29.82M |
After-tax profit from continuing operations | -91.24%7.05M | 219.11%162.21M | 37.93%80.48M | 190.82%50.83M | 115.64%58.35M | 92.60%-55.97M | 106.84%27.06M | -1,300.95%-756.74M | -1,144.60%-395.85M | 57.51%-54.02M |
Earning after tax | -91.24%7.05M | 219.11%162.21M | 37.93%80.48M | 190.82%50.83M | 115.64%58.35M | 92.60%-55.97M | 106.84%27.06M | -1,300.95%-756.74M | -1,144.60%-395.85M | -114.20%-54.02M |
Profit attributable to shareholders | -91.24%7.05M | 219.11%162.21M | 37.93%80.48M | 190.82%50.83M | 115.64%58.35M | 92.60%-55.97M | 106.84%27.06M | -1,300.95%-756.74M | -1,144.60%-395.85M | -113.54%-54.02M |
Basic earnings per share | -90.80%0.0008 | 216.36%0.0174 | 38.10%0.0087 | -8.33%0.0055 | 117.24%0.0063 | 107.38%0.006 | 106.82%0.0029 | -1,301.72%-0.0813 | -1,136.59%-0.0425 | -112.98%-0.0058 |
Diluted earnings per share | -90.80%0.0008 | 216.36%0.0174 | 38.10%0.0087 | 0.0055 | 0.0063 | |||||
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Ernst & Young | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data